Effects of BCI-based lower limb robots on lower limb function and cognition in stroke patients: a preliminary systematic review
Frontiers in Human Neuroscience · 02.07.2026 · 20
DOI: 10.3389/fnhum.2026.1782862 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Human Neuroscience, online erschienen am 02.07.2026. Verfasst von Mengqi Shao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Rehabilitation Medicine Department, Yangzhou Second People's Hospital, Yangzhou, Jiangsu, China. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Schlaganfall
Abstract (Originalsprache)
Background
BCI-based lower limb robots (BCI-LLR) represent a novel technology used in neurological rehabilitation for stroke patients. However, the effectiveness of BCI-LLR compared to traditional rehabilitation in improving lower extremity function and cognition remains a topic of debate. This study aimed to determine whether BCI-based lower limb robots are more effective than traditional rehabilitation for lower limb dysfunction after stroke.
Methods
A comprehensive search was conducted across multiple databases, including PubMed, Embase, Web of Science, and Cochrane Library. The database retrieval was performed up until November 21, 2025. A systematic review of findings was conducted due to the limited number and the heterogeneity of studies.
Results
A total of four studies (three RCTs and one single-arm pre-post study) with 117 stroke patients were included. BCI-LLR training significantly improved lower limb function, with one RCT showing significant between-group differences in FMA-L (+4.5 vs. +2.1, p = 0.022), and another RCT demonstrating significant advantages in TUG (−12.03 vs. −4.65 s, p = 0.038) and BBS (+5.50 vs. +3.38, p = 0.042). The single-arm study also reported significant improvements in all lower limb outcomes ( p < 0.01). For cognition, SDMT improvements significantly favored BCI-LLR in two RCTs ( p = 0.036 and p = 0.013) and in the single-arm study ( p = 0.047). MoCA showed improvement only in the single-arm study ( p = 0.044). The attention index increased significantly in three studies ( p < 0.01). Neurophysiological benefits were reported in one RCT ( p < 0.05).
Conclusion
Preliminary evidence suggests BCI-LLR may improve lower limb function (FMA, BBS, TUG) and information processing speed (SDMT). However, effects on global cognition (MoCA) remain unclear, and sample sizes are critically small.
Systematic review registration
This study was registered on the international system evaluation registration platform PROSPERO (CRD420251232191).
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Rehabilitation Medicine Department, Yangzhou Second People's Hospital, Yangzhou, Jiangsu, China.
- Blood Purification Center, Northern Jiangsu People's Hospital, Yangzhou, Jiangsu, China.
- Rehabilitation Medicine Department, Northern Jiangsu People's Hospital, Yangzhou, Jiangsu, China.
- Rehabilitation Medicine Department, Sunshine Union Hospital, Weifang, Shandong, China.
Zitieren
APA
Shao, M., Wang, X., Wang, K., Yang, K., Zou, A., Chen, B., Zhang, H., Meng, Z., & Jin, X. (2026). Effects of BCI-based lower limb robots on lower limb function and cognition in stroke patients: a preliminary systematic review. Frontiers in Human Neuroscience, 20. https://doi.org/10.3389/fnhum.2026.1782862
Vancouver
Shao M, Wang X, Wang K, Yang K, Zou A, Chen B, et al. Effects of BCI-based lower limb robots on lower limb function and cognition in stroke patients: a preliminary systematic review. Frontiers in Human Neuroscience. 2026;20. doi:10.3389/fnhum.2026.1782862
BibTeX
@article{Shao2026,
author = {Shao, Mengqi and Wang, Xiurong and Wang, Kui and Yang, Kang and Zou, Andi and Chen, Bo and Zhang, Hui and Meng, Zhaoxiang and Jin, Xing},
title = {Effects of BCI-based lower limb robots on lower limb function and cognition in stroke patients: a preliminary systematic review},
journal = {Frontiers in Human Neuroscience},
year = {2026},
volume = {20},
doi = {10.3389/fnhum.2026.1782862}
}
EUVIMED